Intravenous Immunoglobulin for Repeated IVF Failure and Unexplained Infertility

American Journal of Reproductive Immunology

Volumn 68, Issue 3, 2012, Pages 218-225

  Virro, Michael R ^a   Winger, Edward E ^b   Reed, Jane L ^b  

^a Markham Fertility Centre   (Canada)

^b Laboratory for Reproductive Medicine and Immunology   (United States)

Author keywords

Blastocyst; Embryo quality; Immunotherapy; Natural killer cell; Repeat IVF failure; Th1 Th2 ratio; Unexplained infertility

Indexed keywords

ADALIMUMAB; GAMMA INTERFERON; GANIRELIX; HUMAN MENOPAUSAL GONADOTROPIN; IMMUNOGLOBULIN; INTERLEUKIN 10; LEUPRORELIN; RECOMBINANT FOLLITROPIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; BLASTOCYST; DATA BASE; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; BLASTOCYST; DATABASES, FACTUAL; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFERTILITY; OVUM; PREGNANCY; PREGNANCY RATE; TREATMENT FAILURE;

EID: 84865302851     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01169.x     Document Type: Article

References (63)

1. HFEA Fertility treatment in 2010: Trends and figures. Last accessed Dec 11 2011, http://www.hfea.gov.uk/6771.html.
2. Canadian ART Register (CARTR) latest annual figures. Last accessed, Dec 11 2011. http://www.cfas.ca/index.php?option=com_content&view=article&id=1129%3Alive-birth-rates-2011&catid=929%3Apress-releases&Itemid=460.
3. Kaider AS, Kaider BD, Janowicz PB, Roussev RG: Immunodiagnostic evaluation in women with reproductive failure. Am J Reprod Immunol 1999; 42:335-346.
4. Medawar PB: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7:320-338.
5. Scher J, Salazar C: Clinical experience with IVIg Rx in patients with prior failed IVF pregnancies: report of 30 consecutive patients. Am J of Reprod Immunol 2000; 44:121-124.
6. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
7. Mosmann TR, Sad S: The expanding universe of T cell subsets-Th1, Th2 and more. Immunol Today 1996; 17:138-146.
8. Lin H, Mossmann TR, Guilbert L, Tuntipopat L, Wegmann TG: Synthesis of T Helper -2 cytokines at the maternal fetal interface. J Immunol 1993; 151:4562-4573.
9. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi N, Al-Shamali E: Maternal Th1- and Th2-Type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122-130.
10. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
11. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:77-86.
12. Thum MY: The relationship of systemic TNF-alpha and IFN-gamma with IVF treatment outcome and peripheral blood NK cells. Am J Reprod Immunol 2007; 57:210-217.
13. Coulam CB, Goodman C, Roussev RG, Thomasen EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
14. Beer AE, Kwak JY, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35:376-382.
15. Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
16. Balasch J, Creus M, Fabregues F, Font J, Martorell J, Vanrell JA: Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril 1996; 65:655-658.
17. Mangubat CP, Thaker PP, Cavalcante M, Kwak-Kim JYH, Beer AE: Etanercept and immune treatment in multiple IVF failures. ASRI XXI Annual Meeting, Chicago, June 9-12, 2001. Am J Reprod Immunol 2001; 45:345-346.
18. ®) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
19. Graphou O, Chioti A, Pantazi A, Tsukoura C, Kontopoulou V, Guorgiadou E, Balafoutas C, Koussoulakos S, Margaritis LH, Varla-Leftherioti M: Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49:21-29.
20. Yamada H, Morikawa M, Furuta I, Kato EH, Shimada S, Iwabuchi K, Minakami H: Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003; 49:84-89.
21. Kruse C, Varming K, Christiansen OB: Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod 2003; 18:2465-2472.
22. Clark DA, Coulam CB, Stricker RB: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006; 23:1-13. Erratum: 2006;23:383.
23. Clark DA: Immunological factors in pregnancy wastage: fact or fiction. Am J Reprod Immunol 2008; 59:277-300.
24. Stricker RB, Steinleitner AS, Winger EE: Intravenous immunoglobulin (IVIG) therapy for immunologic abortion. Clin Appl Immunol Rev 2002; 2:187-199.
25. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C: Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010; 25:2203-2209.
26. Clark DA: Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: methodological problems. Hum Reprod 2011; 26:2586-2587.
27. Van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA: Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 2007; 58:447-459.
28. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M: Elevated preconception CD56+16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. Am J Reprod Immunol 2011; 66:394-403.
29. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M: Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol 2011; 65:610-618.
30. Kazatchkine M, Kaveri S: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345:747-755.
31. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP: High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1:1228-1231.
32. Luke PP, Scantlebury VP, Jordan ML, Vivas CA, Hakala TR, Jain A, Somani A, Fedorek S, Randhawa P, Shapiro R: Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 2001; 72:419-422.
33. Sokos DR, Berger M, Lazarus HM: Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 2002; 8:117-130.
34. Casadei DH, del C Rial M, Opelz G, Golberg JC, Argento JA, Greco G, Guardia OE, Haas E, Raimondi EH: A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001; 71:53-58.
35. th World Congress on Fertility and Sterility. October 4-9, San Francisco, California, 1998.
36. Lee ET: Statistical Methods for Survival Data Analysis. Belmont, CA, Lifetime Learning Publications, 1980, pp 384.
37. Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M: Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 2005; 174:5837-5845.
38. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV: Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 2006; 203:789-797.
39. Samuelsson A, Towers TL, Ravetch JV: Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291:484-486.
40. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV: Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 2003; 18:573-581.
41. Nimmerjahn F, Ravetch JV: The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 2007; 204:11-15.
42. van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, Deelder AM, Hazes JM, Dolhain RJ: Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 2009; 11:R193.
43. Clark DA, Wong K, Banwatt D, Chen Z, Liu J, Lee L, Gorczynski RM, Blajchman MA: CD200-dependent and nonCD200-dependent pathways of NK cell suppression by human IVIG. J Assist Reprod Genet 2008; 25:67-72.
44. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50:351-354.
45. Clark DA: Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure? J Assist Reprod Genet 2003; 20:63-72.
46. Kwak-Kim JYH, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE: A Gilman-Sachs: increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
47. Kwak-Kim JYH, Gilman-Sachs A, Kim CE: T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy 2005; 88:64-79.
48. Beer AE: Th-1/Th-2 natural killer cell activation systemically and locally in the endometrium and therapeutic options, ASRI XXI Annual Meeting, Chicago, June 9-12, 2001.
49. Mangubat CP, Thaker PP, Cavalcante M, Kwak-Kim JYH, Beer AE: Etanercept and immune treatment in multiple IVF failures. ASRI XXI Annual Meeting, Chicago, June 9-12, 2001.
50. Winger EE, Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60:8-16.
51. Check JH, Liss JR, Check ML, Diantonio A, Duroseau M: Lymphocyte immunotherapy can improve pregnancy outcome following embryo transfer (ET) in patients failing to conceive after two previous ET. Clin Exp Obstet Gynecol 2005; 32(1):21-22.
52. Kong LH, Liu Z, Li H, Chen SM, Xing FQ: [Allogeneic leukocyte immunization combined with IVF-ET for treatment of infertility induced by recurrent spontaneous abortion]. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28:1300-1301.
53. Gatenby PA, Cameron K, Simes RJ, Adelstein S, Bennett MJ, Jansen RP, Shearman RP, Stewart GJ, Whittle M, Doran TJ: Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 1993; 29:88-94.
54. Recurrent miscarriage immunotherapy trialists group: worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:55-72.
55. CARTR statistics 2010. Last accessed Dec 11, 2011. http://www.cfas.ca/index.php?option=com_content&view=article&id=1130:2010cartr-results&catid=1012:cartr&Itemid=670.
56. Meldrum DR, Silverberg KM, Bustillo M, Stokes L: Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil Steril 1998; 69:1005-1009. Review.
57. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB: Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000; 73:1155-1158.
58. Clark DA: The power of observation. Am J Reprod Immunol 2011; 66:71-75.
59. Clark DA: Corrigendum. Am J Reprod Immunol 2011; 66:162.
60. Lin H, Mossmann TR, Guilbert L, Tuntipopat L, Wegmann TG: Synthesis of T Helper -2 cytokines at the maternal fetal interface. J Immunol 1993; 151:4568.
61. + regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil Steril 2009; 92:301-305.
62. Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E: Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 59:242-250.
63. Kwak JY, Gilman-Sachs A, Moretti M, Beaman KD, Beer AE: Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am J Reprod Immunol 1998; 40:352-358.